Introduction {#S1}
============

There are growing numbers of older people training and competing as Masters runners in mass-participation endurance events, such as 5, 10 km, Half Marathon or full Marathons ([@B64]; [@B35]). At the highest competitive level, Masters runners train 4--7 times per week at high intensity ([@B51]). Their overall lifestyle includes more physical activity than the general population, as they accumulate around 3-fold more low impacts as a result of voluntary movement during general activities, 20-fold more medium impacts and 200-fold more high impacts (measured in units of gravity, *g*) compared with typical older adults from the general population ([@B12]; [@B22]).

Intense training sustained through middle and into older age helps to maintain low body fat percentage ([@B54]) and, possibly, greater lean mass and skeletal muscle strength into old age. However, the available evidence regarding muscle mass and function of older Masters runners is conflicting. A recent meta-analysis highlighted research gaps due to most studies having low participant numbers with very few female athletes, limited outcome assessments and unclear demographics ([@B39]). For example, two studies ([@B56]; [@B63]) showed higher maximal force or power in Masters endurance runners compared with non-athletic old, but several others showed no difference between Masters endurance runners and controls ([@B1]; [@B43]; [@B44]; [@B10]; [@B53]; [@B51]) or even lower ([@B62]; [@B59]) maximal force or power in Masters endurance runners compared with non-athletic old. More recently, [@B15] reported high levels of physical function, low body fat, and good health status of Masters athletes, but these characteristics declined with advancing age and because no comparison was made with non-athletic old it is not possible to know if these characteristics were any better than typical healthy old. Differences between studies in the athletic ranking of Masters athletes (e.g., highest achievements), age and years of training are possible explanations for the conflicting reports, but there is very little information available to show how the starting age influences physical performance, muscle mass, and body composition in later life.

In the general population, leg skeletal muscle mass declines progressively from age 30 years at a rate of approximately 8--10% per decade ([@B37]; [@B28]; [@B33]; [@B45]; [@B46]) and maximal force and power decline progressively at approximately 10--12% per decade ([@B43]; [@B13]; [@B3]). Therefore, by age 50 years non-athletic men and women have typically undergone two decades of progressive muscle declines. If regular endurance running preserves muscle structure and function into older age ([@B58]; [@B32]; [@B60]), then life-long athletes should have avoided these age- and lifestyle-dependent declines and should have greater muscle mass and function than those taking up running after the age of 50 years. Although no research is available to support these possible benefits of longer-term training, there is evidence to suggest that starting age is an important factor. A previous study of Masters tennis players found that the upper limb (radius, ulna, and humerus) bone circumference and bone mineral density were greater in those who started training at an early age compared with those starting at an older age ([@B26]). However, this study did not examine muscles or bones of the legs that would be exposed to "impacts" during running. More crucially, the positive influence of playing tennis from a young age for arm bones conflicts with other data suggesting that long-term endurance running does not give higher bone mineral density or may even be detrimental for spine, leg or hip bone mineral density ([@B38]; [@B74]; [@B51]).

There is a gap in available knowledge of whether the age at which people take up competitive endurance running influences musculoskeletal structure and function as well as body composition in later life. These questions are important because regular exercise is recommended as the best way to combat age-related declines of the musculoskeletal system ([@B2], [@B30]; [@B8]; [@B11]) and the age at onset of exercise may affect health and performance-related indicators in later life. We therefore aimed to compare body composition, lean mass, maximal power, and hip and spine bone mineral density between Masters endurance runners competing all of their adult lives with those taking up competitive running after the age of 50 years. For reference, a non-athletic healthy older group was also included. It was hypothesized that athletic performance, lean mass, muscle power, and bone mineral density would be greater in trained compared with untrained adults, and greater in those with the longer history of athletic training compared to those starting athletic training after the age of 50 years.

Materials and Methods {#S2}
=====================

Study Design {#S2.SS1}
------------

The study was approved by the Regional Ethics Committee (North West England: 14/NW0275) as well the Local Ethics Committee of Manchester Metropolitan University. Written informed consent was obtained from all participants. Masters runners were recruited as part of the United Kingdom-based "VIBE" study ([@B12]; [@B22]). Male and female athletes were recruited from regional athletics meetings from across the United Kingdom. To be included, they must have been aged ≥59 years at the point of enrollment, had competed in endurance running in the past 12 months at a regional level and free from serious injury for over 2 years. They were invited to attend the research facility at Manchester Metropolitan University (United Kingdom) and were required to avoid training or competing for at least 48 h prior to attendance. The full cohort included 188 Masters Athletes, of which 33 were sprinters (events less than or equal to 400 m) and 150 were endurance runners (events greater than or equal to 800 m). Given the low number of sprinters (when separated to early starters, late starters, men, and women) and the known differences in muscle mass and bone mineral density between sprinters and endurance runners ([@B18]; [@B30]; [@B51]), the sprinters were excluded from further analysis for this particular study. Thus, a total of 150 Masters endurance runners were available for analysis. Mean age-graded performance (AGP) was determined by taking the athlete's highest ranked performance within the last 2 years and expressing it as a percentage of the world record for that age and distance. AGP ranged from 77--92% across the cohort, indicating a very high level of performance relative to age group records. For example, a 3 h and 30 min marathon for a 70-year-old man gives an age-graded performance of 80%, as described previously ([@B51]).

Data for control participants was taken from the MYOAGE study, a European multi-center study of healthy aging and the methodology has been described previously ([@B42]). These participants were recruited by focused advertisement in newspapers, the third-generation university and the association of emeriti and universities, thus selecting cognitively active individuals living independently and without mobility impairments. An initial telephone interview was used to screen volunteers, which asked for self-reported number of exercise and social activity sessions per week over the past 3 years. Those who were sedentary defined as not involved in any regular activity sessions, as well as those involved in any form of regular, intense athletic or gym training were excluded from the control group. The controls did not complete accelerometry-based activity monitoring for use in this study. For the purpose of this study the 59 older participants recruited at the Manchester, United Kingdom, site and with complete data including hip and spine bone mineral density measurements were used.

Therefore, the total number of complete datasets available for analysis was 209 and all participants completed measurements at the same laboratory and using the same equipment. Of those, 140 were male and 69 were female. For this study, the athletes were divided into early starter (ES) and late starter (LS) athletes. These groups were based on answers from a questionnaire asking each athlete to self-report the number of hours spent training (0--1, 2--3, 4--7, over 7 per week) during different stages of their adult life (18--29, 30--49 and 50 years and over). Early starter athletes were defined as those that had taken part in competitive endurance running throughout their adult lives, reporting intense training and competition at ages 18--29, 30--49, and 50 years and over. Late starter athletes were defined as those that had taken up intense training and competition after the age of 50 years, with no previous competitive training history. See [Table 1](#T1){ref-type="table"} for participant characteristics.

###### 

Participant characteristics.

  **Variable**                                             **Group**              **ANCOVA**             **Pairwise comparisons**   ***Covariate***                                                                                                                                   
  -------------------------------------------------------- ---------------------- ---------------------- -------------------------- ---------------------- -------------- -------------- -------------- -------------- -------------- -------------- -------------------------------- -----------------------------
  Adulthood training years                                 52.3 ± 6.0             47.6 ± 4.2             18.4 ± 5.1                 19.4 ± 5.2             N/A            N/A            **\>0.0005**   **\>0.0005**   **\>0.0005**   **\>0.0005**   F(1,184) = 0.007, p = 0.934      F(1,184) = 286, p \< 0.0005
  95% CI                                                   50.7--53.9             43.7--53.2             17.1--19.7                 17.2--20.9                                                                                                                                        
  Age (years)^a^                                           71.3 ± 5.8             66.4 ± 3.0             68.8 ± 5.5                 69.6 ± 5.1             74.1 ± 5.7     73.3 ± 4.5     **\>0.0005**   0.095          **0.004**      **\>0.0005**   F(2,242) = 15.8, p \< 0.0005     n/a
  95% CI                                                   70.1--73.2             62.9--71.6             67.4--70.1                 67.7--71.2             71.9--76.2     71.6--74.9                                                                                                  
  Height (cm)                                              171.2 ± 5.6            164.2 ± 4.5            174.0 ± 6.3                161.6 ± 6.9            172.0 ± 8.7    160.3 ± 5.1    0.411          --             --             --             F(1,242) = 0.142, p = 0.706      (1,242) = 0.455, p = 0.500
  95% CI                                                   169.9--173.0           158.4--167.0           172.7--175.6               159.5--164.2           168.6--175.3   158.4--162.3                                                                                                
  Body mass (kg)                                           68.3 ± 8.7             55.4 ± 4.7             67.5 ± 6.8                 56.1 ± 7.8             80.2 ± 16.2    63.1 ± 11.5    **\>0.0005**   0.823          **\>0.0005**   **\>0.0005**   F(1,242) = 84.132, p \< 0.0005   F(1,242) = 0.423, p = 0.516
  95% CI                                                   67.2--72.4             52.2--60.2             66.8--70.3                 54.3--59.7             74.1--86.4     58.8--67.4                                                                                                  
  BMI (kg/m^2^)                                            22.7 ± 4.3             20.5 ± 1.9             22.3 ± 1.9                 21.6 ± 2.1             27.1 ± 4.7     24.5 ± 4.2     **\>0.0005**   0.864          **\>0.0005**   **\>0.0005**   F(1,242) = 7.151, p = 0.008      F(1,242) = 0.080, p = 0.778
  95% CI                                                   22.1--24.5             20.0--22.4             22.1--23.1                 21.1--22.6             25.3--28.8     23.0--26.1                                                                                                  
  Accelerometry low impact (0.5--1 g) counts^b^            33529 (21051--46725)   55066 (35520--64137)   44404 (32394--57262)       35637 (23960--52961)                  0.089          0.089          --             --             --             F(1,175) = 1.48, p = 0.226       
  95% CI                                                   28539--40384           19985--56368           39101--50240               32315--46670                                                                                                                                      
  Accelerometry medium impact (1--1.5 g) counts^b^         27565 (10700--50689)   29465 (23566--59147)   34901 (23648--49685)       29868 (20319--40853)                  0.80           0.799          --             --             --             F(1,175) = 0.717, p = 0.398      
  95% CI                                                   20501--36133           9973--42399            28665--39081               24249--40448                                                                                                                                      
  Accelerometry (counts) high impact (\>1.5 g) counts^b^   172 (9--1214)          89.6 (50--1572)        221 (32--932)              119 (10--745)                         0.35           0.352          --             --             --             F(1,175) = 0.035, p = 0.851      
  95% CI                                                   386--1217              −269.1--1511           549--3070                  −842--5272                                                                                                                                        
  Age graded performance (%)                               74.5 ± 1.6             84.3 ± 2.2             77.8 ± 1.3                 79.8 ± 1.9                            0.29           0.294          --             --             --             F(1,174) = 4.137, p = 0.043      
  95% CI                                                   72.2--78.3             83.3--92.6             76.1--81.8                 76.5--83.8                                                                                                                                        

Data are mean ± SD. Age and sex were included as covariates, except where indicated by

a

where sex was the only covariate.

b

Data are presented as median (25th/75th) quartiles. 95% Confidence intervals (95%CI). Bold text is used to highlight statistically significant difference (

p

\< 0.05).

Questionnaires {#S2.SS2}
--------------

Participants provided demographic, general health, lifestyle, and physical activity information by questionnaire \[described previously ([@B22])\]. Self-rated health was reported on a scale from very good through to very poor, along with details of any diseases or prescribed medications. Current and history of smoking was collected, including number of cigarettes smoked per normal day, age started smoking and the duration, if ever, of smoking. Typical alcohol consumption was recorded and the type of alcohol. Highest level of education was also recorded. Questionnaire response data has been provided in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}.

Accelerometry {#S2.SS3}
-------------

Accelerometry data was collected only in the athletes and has been described previously ([@B12]; [@B51]). Each athlete received a GCDC × 16--1c (Gulf Coast Data Concepts, Waveland, MS, United States), which was placed in a Velcro strap and worn tightly around the waist with the accelerometer device placed over their right hip. Each athlete wore a monitor for seven consecutive days, only removing it when showering, bathing, swimming, and sleeping. Each athlete completed a time sheet over the 7-day period to record when the monitor was worn and to indicate any reason why that day was not representative of their usual routine. Accelerometers were configured with standardized settings prior to participant use with a sampling frequency of 50 Hz, a deadband setting of 0.1 g (the threshold which must be exceeded before a recording is made) and a timeout setting of 10 s (meaning that a single sample every 10 s is taken even if the recording is \<0.1 g) ([@B12]). Once the 7 day period of use was completed the participant returned the accelerometer to the research facility by post. The raw accelerometry data was uploaded to a secure shared drive and read into Stata 13 (StataCorp, College Station, TX, United States). A standardized cleaning and processing procedure was used and has been described in detail previously ([@B12]). In short, the *Y*-axis accelerations dataset was cleaned to remove any movement artifacts and any periods of nil data collection, most likely due to the participant not wearing the accelerometer. Activity data were normalized based on seven valid days of 14 h with ≥10 h recording time. *Y*-axis peaks were calculated based on accelerations that were higher than the previous and subsequent reading and recorded within 14 pre-specified g bands. These were condensed to three impact bands; low (≥0.5 to \<1.0 g), medium (≥1.0 to \<1.5 g) and higher (≥1.5 g) impact. All *g* values represent *g* over and above 1 *g* from earth's gravitational force ([@B21]).

DXA Scans {#S2.SS4}
---------

Standing height was measured to the nearest millimeter and body mass was measured to the nearest 0.1 kg. Whole body, total hip and lumbar spine dual energy X-ray absorptiometry (DXA: Lunar Prodigy Advanced, GE Healthcare, encore version 10.50.086, London, United Kingdom) scans were performed while the participant lay supine wearing a light cotton t-shirt to reduce measurement errors due to clothing absorption. Body composition (fat mass and lean mass) was taken from results of total body scans and regional analysis of legs and arms. Bone mineral density (BMD, g.cm^--2^) was taken from hip and spine scans. All measurements were recorded after manual adjustment of the regions of interest. Repeat total body and hip scans were performed in eight participants within 1 month of the first scan. Using these repeat scans, the short-term error for our laboratory was 2.0% for hip BMD, 0.9% for spine BMD and 0.01% for whole body lean mass.

Muscle Function {#S2.SS5}
---------------

The investigators provided verbal instructions and a physical demonstration of the muscle function tests. Participants were allowed one practice immediately before the actual assessed trials, which acted as a specific warm up and also confirmed that the instructions were understood. In all cases, the muscle function tests were completed between 10 am and 3 pm.

Hand grip strength was measured using the Jamar dynamometer handle (Sammons Preston Inc., Bolingbrook, IL, United States) as previously described ([@B23]). The width of the dynamometer was adjusted for each participant separately. Participants were instructed to stand upright with the arm fully extended along the body, maintaining approximately 5 cm gap between the wrist and the hip or upper leg (so that the hand was not rested against the body). Participants were instructed to squeeze against the handle as hard possible for 3 seconds. Grip strength was measured three times and recorded in kilograms to the nearest 0.1 kg. For the purpose of this study, the best of three attempts was included in further analysis.

A Leonardo Jump Mechanography Platform (Leonardo Software version 4.2: Novotiec Medical GmbH, Pforzheim, Germany) was used to assess lower limb muscle power during a countermovement vertical jump, as described previously ([@B23]). Results for both absolute (W) and relative (W/kg) power were recorded. Briefly, a two-footed countermovement jump was performed starting with feet approximately 30 cm apart (slightly narrower than shoulder width) and standing upright on the force plates. Force was sampled at 800 Hz. Participants flexed at the knees before extending as forcefully as possible to take off for the jump. Jumps were performed with a trained research assistant in close proximity to intervene in case of a trip or fall. Each participant repeated the jump sequence three times, with approximately 60 seconds rest between efforts. The jump with the highest value for power was used for statistical analysis.

Statistical Analysis {#S2.SS6}
--------------------

Statistical analysis was performed using SPSSv21 (IBM, United States). Normality of distribution was assessed using the Shapiro--Wilk test, which showed that all data was normally distributed (presented as mean ± standard deviation) except for accelerometry data (presented as median (25th/75th) quartiles). Two-way ANOVAs (three group and two sex; all *p* \> 0.05) showed no group × sex interactions for any of the variables so for this reason, together with the relatively small numbers of females in the ES group, data from both sexes were included within the same analysis. Univariate ANOVA (ANCOVA) analysis was used to identify differences between the three groups (ES, LS, and C) with age and sex added as covariates, to account for the different mean ages and proportions of males and females between groups. Where significant differences were found, Fisher's Least Significant Difference pairwise comparisons were performed. Differences between groups were considered statistically significant at *p* \< 0.05.

As participants included in our study were initially recruited to address other primary research questions, sample sizes for our analyses were fixed by the data already available. Our power to determine small, medium and large effect sizes can be ascertained from the observed effect sizes for the different outcome variables based on the partial eta squared (η^2^*p*), as recommended by [@B31] and [@B49] for use with ANOVA analysis including covariates (age and sex). A small effect size was set at η^2^*p* = 0.01, a medium effect size was set at η^2^*p* = 0.06 and a large effect size was set at η^2^*p* = 0.14. The values provided in the Results section show that the study was sufficiently powered to detect even small differences between groups for the main outcome variables of body fat percentage, lean mass, spine BMD, and vertical jump power.

Results {#S3}
=======

Participant Characteristics {#S3.SS1}
---------------------------

Participant characteristics are shown in [Table 1](#T1){ref-type="table"} and other health and demographic information has been provided in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}. The ES athletes had been training for 30 years longer than LS athletes (*p* \< 0.0005). Pairwise comparison showed there was no significant difference between ES and LS for AGP (*p* = 0.294). Accelerometry collected over 7 days showed similar impacts in the low, medium, and high *g* bands between ES and LS groups (*p* = 0.089, 0.799, and 0.352, respectively, as shown in [Table 1](#T1){ref-type="table"}).

There was no significant difference between groups for height. However, age, body mass, and BMI were significantly different between groups (all *p* \< 0.0005). Pairwise comparisons showed that C were older than ES and LS, with no difference between ES and LS groups. Body mass and BMI were similar for the ES and LS athletes, but significantly greater for C compared with ES and LS groups (both *p* \< 0.0005). The main reason for greater body mass in C was the higher body fat percentage ([Figure 1B](#F1){ref-type="fig"}).

![Body fat percentage and leg lean mass. Data shown as mean ± SD and individual data points also displayed as open circles. **(A)** Body fat expressed as a percentage of total body mass, significance assessed when adjusting for Gender \[*F*(1,242) = 44.2, *p* \< 0.01\] and age \[*F*(1,242) = 2.07, *p* = 0.15\]. **(B)** Leg lean mass significance assessed when adjusting for Gender \[*F*(1,242) = 179, *p* \< 0.01\] and age \[*F*(1,242) = 8.40, *p* \< 0.01\]. ES, Early Starter; LS, Late Starter; C, Controls. ^∗∗∗^ Significantly different to controls at *p* \< 0.01 and ^∗^ at *p* \< 0.05.](fphys-10-01050-g001){#F1}

Muscle Function and Body Composition {#S3.SS2}
------------------------------------

Total body fat percentage differed significantly between groups (*p* \< 0.0005; η^2^*p* = 0.380) due to approximately 17% lower values for both athlete groups than C (*p* \< 0.01; [Figure 1A](#F1){ref-type="fig"}). Leg lean mass differed significantly between groups (*p* \< 0.0005; η^2^*p* = 0.098; [Figure 1B](#F1){ref-type="fig"}), being approximately 12% greater in both athlete groups than C (*p* \< 0.003). Appendicular lean mass was also different between groups (*p* = 0.003; η^2^*p* = 0.062) and although values were similar between athlete groups, the LS had a significantly greater lean mass than C (*p* = 0.001). Total body lean mass did not differ significantly between groups (η^2^*p* = 0.028; [Table 2](#T2){ref-type="table"}).

###### 

Musculoskeletal characteristics.

  **Variable**                          **Group**     **ANCOVA**    **Pairwise comparisons**   ***Covariate***                                                                                                                            
  ------------------------------------- ------------- ------------- -------------------------- ----------------- -------------- ------------- -------------- ------- ------------------ ------------------ ------------------------------ ------------------------------
  Total body lean mass (kg)             53.3 ± 8.77   43.1 ± 9.48   54.8 ± 6.1                 41.0 ± 9.4        52.3 ± 0.9     38.1 ± 4.3    0.215                                                        F(1,242) = 280, p \< 0.0005    F(1,243) = 6.29, p = 0.013
  95% CI                                51.5--55.1    40.6--45.5    53.6--56.0                 39.1--42.8        49.0--55.8     36.4--39.5                                                                                                
  Total body fat mass (kg)              11.9 ± 5.26   10.4 ± 4.02   9.92 ± 4.23                13.2 ± 5.06       24.6 ± 10.3    22.4 ± 9.00   **\>0.0005**   0.494   **\<0**.**0005**   **\<0**.**0005**   F(1,203) = 0.477, p = 0.490    F(1,203) = 0.011, p = 0.917
  95% CI                                10.3--13.4    6.14--14.6    8.84--11.0                 11.4--15.1        20.7--28.9     19.0--25.7                                                                                                
  Appendicular lean mass (kg)           26.0 ± 0.5    19.7 ± 0.7    26.9 ± 0.5                 19.0 ± 0.5        23.6 ± 0.8     16.5 ± 0.4    **0.003**      0.084   0.140              **0**.**001**      F(1,242) = 201, p \< 0.005     F(1,242) = 10.9, p = 0.001
  95% CI                                25.0--27.0    19.0--22.2    26.2--28.1                 17.8--20.0        22.0--25.4     15.7--17.3                                                                                                
  Spine BMD (g/cm^2^)                   1.11 ± 0.02   0.93 ± 0.05   1.08 ± 0.16                0.88 ± 0.03       1.15 ± 0.03    0.95 ± 0.03   **0.004**      0.149   0.087              **0**.**001**      F(1,242) = 71.0, p \< 0.005    F(1,242) = 0.77, p = 0.412
  95% CI                                1.09--1.18    0.87--1.12    1.06--1.13                 0.83--0.95        1.08--1.21     0.88--0.99                                                                                                
  Spine BMC (g)                         271 ± 8.44    185 ± 18.6    249 ± 8.66                 186 ± 1.16        300 ± 12.7     196 ± 11.3    **0.001**      0.091   0.073              **\<0**.**0005**   F(1,242) = 60.2, p \< 0.0005   F(1,242) = 0.070, p = 0.791
  95% CI                                256--294      140--303      240--272                   173--203          275--331       167--216                                                                                                  
  Spine area (cm^2^)                    244 ± 4.32    196 ± 10.4    236 ± 3.44                 202 ± 3.83        260 ± 6.16     204 ± 8.30    **0.014**      0.403   0.062              **0**.**004**      F(1,242) = 77.2, p \< 0.0005   F(1,242) = 0.002, p = 0.966
  95% CI                                238--253      172--255      231--244                   195--210          249--277       182--220                                                                                                  
  Hip BMD (g/cm^2^)                     1.05 ± 0.02   0.92 ± 0.06   1.02 ± 0.02                0.88 ± 0.02       1.05 ± 0.02    0.88 ± 0.02   0.094                                                        F(1,236) = 58.7, p \< 0.0005   F(1,236) = 8.57, p = 0.004
  95% CI                                1.04--1.12    0.85--1.03    1.00--1.07                 0.85--0.93        1.00--1.10     0.81--0.92                                                                                                
  Hip BMC (g)                           39.7 ± 0.86   30.6 ± 1.96   37.2 ± 0.89                29.1 ± 0.72       39.0 ± 1.80    28.3 ± 0.94   0.135                                                        F(1,236) = 95.5, p \< 0.0005   F(1,236) = 0.372, p = 0.543
  95% CI                                39.1--42.3    28.5--34.4    36.6--40.1                 28.1--30.8        35.3--43.2     25.8--29.9                                                                                                
  Hip area (cm^2^)                      37.9 ± 0.53   33.4 ± 0.37   37.0 ± 0.70                33.3 ± 0.40       38.1 ± 063     32.3 ± 0.48   0.617                                                        F(1,236) = 69.6, p \< 0.0005   F(1,236) = 6.45, p = 0.014
  95% CI                                37.1--38.9    31.7--35.8    36.1--38.6                 32.3--34.0        37.3--39.7     31.1--33.2                                                                                                
  Maximal grip strength (kg)            36.8 ± 1.2    32.7 ± 3.4    37.3 ± 1.1                 35.0 ± 1.9        38.2 ± 1.2     24.4 ± 0.9    0.142          --      --                 --                 F(1,236) = 32.3, p \< 0.0005   F(1,236) = 6.20, p = 0.014
  95% CI                                35.5--39.8    29.1--37.5    36.3--40.3                 31.9--39.1        35.7--40.9     22.3--26.1                                                                                                
  Vertical jump power (W)               2054 ± 75.8   1359 ± 109    2014 ± 74.6                1420 ± 70.5       2191 ± 112.2   1463 ± 89.5   **0.022**      0.504   0.062              **0**.**006**      F(1,238) = 73.2, p \< 0.0005   F(1,238) = 28.2, p \< 0.0005
  95% CI                                2016--2368    1169--1838    1967--2282                 1314--1612        1997--2481     1243--1646                                                                                                
  Relative vertical jump Power (W/kg)   30.2 ± 1.1    24.5 ± 1.5    30.0 ± 1.1                 25.3 ± 1.1        27.5 ± 1.0     23.0 ± 0.9    0.584          --      --                 --                 F(1,238) = 25.6, p \< 0.0005   F(1,238) = 29.8, p \< 0.0005
  95% CI                                29.1--33.5    20.0--32.7    28.8--33.0                 23.3--27.8        25.8--29.9     21.2--25.0                                                                                                

Data are presented as mean ± SD. Age and sex were included as covariates. Values highlighted in bold text identify significant differences between groups. BMD, Bone mineral density; BMC, Bone mineral content; %Female as displayed in

Table 1

. 95% Confidence intervals (95%CI).

Spine BMD (*p* = 0.004; η^2^*p* = 0.053), BMC (*p* = 0.001; η^2^*p* = 0.064), and Area (*p* = 0.014; η^2^*p* = 0.041) were significantly different between groups. There were no differences for these measurements between athlete groups, but LS had lower BMD (*p* = 0.001; η^2^*p* = 0.053), BMC (*p* \< 0.0005; η^2^*p* = 0.063), and Area (*p* = 0.004; η^2^*p* = 0.041) compared to C. There was no significant difference in Hip BMD (η^2^*p* = 0.024), BMC (η^2^*p* = 0.020) or Area (η^2^*p* = 0.005) between any of the groups ([Table 2](#T2){ref-type="table"}).

Maximal grip strength (η^2^*p* = 0.020) and vertical jump power relative to body mass (η^2^*p* = 0.005) did not differ significantly between groups ([Table 2](#T2){ref-type="table"}). However, vertical jump power in absolute values was different between groups (*p* = 0.020; η^2^*p* = 0.017); values were similar between athlete groups, but controls exhibited a greater power than LS (*p* = 0.006).

Discussion {#S4}
==========

The novel contribution of the present study is the focus on the starting age of Masters endurance runners in relation to later life performance and musculoskeletal health indicators. This is supported by the relatively large sample size, depth of physiological profiling and, for the Masters athletes, objective characterization of habitual physical activities. Our findings demonstrate that the men and women of the LS group with no previous history of intense training or competition before the age of 50 years, had by the age of 70 years very similar training intensity, athletic performance, body fat percentage and leg lean mass to athletes of the ES group whom had accumulated 30 extra years of training and competition ([Table 2](#T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}). Both athlete groups had lower body fat and greater leg lean mass than healthy non-athletic controls, but spine BMD was lower in LS than in C. These findings suggest that starting regular, intense endurance running at, or after, the age of 50 years is not too late to compete at the highest level in Masters endurance running or to significantly delay accumulation of body fat and loss of leg lean mass in older age.

The physical activity levels of ES and LS equates to around 3-fold greater level of low impacts, 20-fold greater level of medium impacts and 200-fold greater level of high impacts per week compared with reference values that were previously reported for older adults from the general population ([@B22]). Past studies have demonstrated both a dose-response and an intensity-dependent response to regular exercise training, as more frequent and higher intensity training confer beneficial health- and performance- adaptations ([@B65]; [@B6]; [@B41]). The high impacts and activity levels due to more vigorous intensity movements alongside the associated energy expenditure is the most likely reason why both athlete groups avoided the usual increase in adiposity with advancing older age ([@B14]).

Appendicular and leg lean mass were similar between athlete groups, but both athlete groups had higher leg lean mass than C ([Table 2](#T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}). This is in line with two studies ([@B44]; [@B10]) that reported greater muscle size of Masters endurance athletes than age-matched controls. These past studies ([@B44]; [@B10]) included only 15 Masters athletes, compared with our much larger sample of 150 endurance runners with detailed activity tracking by accelerometry and confirmation of the high AGP. The prevailing view is that resistance exercise is needed to reduce risk of sarcopenia in old age ([@B11]; [@B34]; [@B70]). Our results suggest that long term intense endurance running is also effective, and that it does not matter if this activity is taken up after the age of 50 years. However, from the available data we are not able to identify an older age at which benefits of intense endurance running are diminished compared with those training for all of their adult lives.

One of the benefits of having larger muscles is the potential to develop greater muscle force and power. In our study, power measured by vertical jump was not different between athlete groups, but actually lower for LS compared with C. However, this difference between groups disappeared when normalized to total body mass ([Table 2](#T2){ref-type="table"}). Previous studies also reported similar vertical jump power in Masters endurance runners and age-matched non-athletic individuals ([@B43]). We did not determine the reasons why the larger muscles of endurance runners do not produce greater power, but it is likely related to the characteristic "slow" muscle fiber contractile properties of endurance athletes ([@B66]) which makes energy turnover more economical, but gives lower power as the product of force x velocity of contractions ([@B43]). We did not measure knee extensor maximal force, but the available evidence is conflicting over the possibility that Master endurance runners have greater maximal force, mainly due to heterogeneity in study populations and several studies with low sample size ([@B39]).

The LS athletes had lower spine BMD, BMC, and Area than C, raising the possibility that starting regular intense endurance running after age 50 years may be detrimental to spine bone health. This may seem counter-intuitive, as it is proposed that regular exercise with high impacts can improve bone mineral density and bone strength ([@B25], [@B27]) as high muscular forces stimulate osteogenic responses ([@B16], [@B17]). However, this previous literature is primarily based on observations of long limb bones ([@B74], [@B75]; [@B25], [@B26]). For example, previous studies showed that the limb bone circumference of Masters athletes (33--94 years old) was greater than that of age-matched sedentary controls ([@B75]). These beneficial effects may be limited to limb bones, younger ages or participation in sprint or power activities ([@B71], [@B72]; [@B75]; [@B26]). Previous research has also demonstrated an inverse association between the amount of low-impact physical activity and hip and spine BMD ([@B29]; [@B22]; [@B51]). Although the explanation is lacking for why completing lots of low impact activity may be detrimental for bones, it is well known that bone responses depend on the type of physical activity being performed ([@B47]; [@B68]; [@B74]; [@B51]; [@B55]). For instance, sprinting is associated with greater hip, spine and tibial BMD compared to endurance running or non-athlete controls ([@B74]; [@B51]). Although not measured in the present study, Vitamin D and calcium intake are also associated with skeletal health in older age ([@B7]). In particular, Vitamin D deficiency and low calcium intake can lead to low bone mineral density and they are used as supplements to combat osteoporosis ([@B19], [@B20]). Therefore, any interventions later in life to improve bone health may need to include nutritional supplementation, and also consider sprint or jumping activities in addition to regular prolonged endurance running.

Overall, our findings build upon available evidence that short-term exercise can improve some features of musculoskeletal health in middle- and older-age ([@B41]) and have highlighted possible benefits of very long-term exercise ([@B68]; [@B74], [@B75]; [@B48]; [@B24]; [@B39]), although these benefits may not be present for lumbar spine bones. The novel contributions of the present study describing the very long-term intense training and the focus on starting age are important because starting at a later age risks the possibility that irreversible age-related declines have already occurred and would limit adaptations that improve health and performance. For example, age-related reduction of maximal heart rate limits cardiac output and therefore peak aerobic capacity. Within the musculoskeletal system the skeletal muscle mass, strength and power decline from the fourth decade of life ([@B37]; [@B28]; [@B61]; [@B57]; [@B46]; [@B50]; [@B15]; [@B3]). The extent to which these changes are related to irreversible reductions of muscle fiber numbers ([@B36]; [@B40]) and motor units ([@B67]; [@B52]; [@B54]) remains unknown. In this respect, the findings of the present study are encouraging. The implication based on observations made from the participants in our study, is that starting intense training in middle age, approximately 20 years after musculoskeletal declines are detectable in the general population, is not a disadvantage compared to training throughout adult life when it comes to maintaining leg muscle mass, preventing accumulation of excessive fat mass and for athletic performance in older age.

The findings of this study may inform practitioners when recommending physical activity for older adults aiming to reduce fat mass, gain leg lean mass or improve bone mineral density. The new information showing that long-term endurance training is associated with greater leg lean mass should be considered by policy makers as an alternative, or addition, to resistance exercise to combat sarcopenia. One note of caution, however, is that the lower bone mineral density of the spine in LS may increase the risk of late life bone injuries.

Study Limitations {#S4.SS1}
-----------------

The grouping of ES and LS has relied on self-reports and the cross-sectional study design prevents any causal relationships from being established. Our sample size of 209 provided sufficient power to detect even small differences in means between comparison groups, but we cannot rule out the possibility that there may be very small differences in outcomes between the ES and LS groups which we were unable to detect. There is also a risk of differences in data handling and screening of bone results (e.g., for spondylosis) when comparing the results of the Masters athletes with those of the controls, where data were collected approximately 5 years apart. However, care was taken to follow exactly the same protocols as far as possible and the assessments were made in the same laboratory using the same equipment. The values for body composition and lean mass of the controls are within the ranges previously published for non-athletic but otherwise healthy older adults from larger, multi-center studies ([@B5]; [@B4]; [@B9]; [@B69]). Nevertheless, interpretation of outcome comparisons for the control group is limited because they did not complete the same physical activity assessments as the Masters athletes. The athletes were recruited based on their athletic performance over the previous 2 years. Within this time period there may have been fluctuations in activity levels due to injury or illness which were not captured within this study. Future studies could shorten the time period taken into account when recruiting the athletes or more carefully consider their time spent inactive. More detailed information about youth physical activity may also add further insights. A B-PAQ questionnaire ([@B73]) may be used in future for this purpose. Studies of Masters athletes carry a possible bias because any individuals developing injury or disease may cease competing and would not be available for recruitment. Masters athletes tend to be better educated, of higher socio-economic status and with fewer diseases than the general population ([Supplementary Table S1](#SM1){ref-type="supplementary-material"}), so the results of such studies may not be generalized to the wider population. Finally, we cannot rule out possible differences in energy intake or nutritional status, particularly of Vitamin D and calcium that influence musculoskeletal health, between athletes and controls because this was not measured in our study.

Conclusion {#S5}
==========

The Masters athletes within our sample taking up intense endurance running after the age of 50 years had lower body fat and higher leg lean mass than non-athletes by the age of 70 years and the values for body composition and athletic performance of the late starters were very similar to those of people whom had trained all of their adult lives.
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